Search results

This notice was published on August 16, 2022.

Tocilizumab (162 mg/0.9 ml (4 ml)), Tocilizumab (162 mg/0.9 ml (10 ml)) et Tocilizumab (162 mg/0.9 ml (20 ml)) remplace:

• Actemra (162 mg/0.9 ml) – S.C. Inj. Sol (syr)
• Actemra (162 mg/0.9 ml) – S.C. Inj. Sol (pen)

This notice was published on August 25, 2022.

Trifluoperazine hydrochloride (5 mg – Caps.), Trifluoperazine hydrochloride (10 mg – Caps.), and Trifluoperazine hydrochloride (20 mg – Caps.) replace:

• Trifluoperazine hydrochloride (5 mg – Tab.)
• Trifluoperazine hydrochloride (10 mg – Tab.)
• Trifluoperazine hydrochloride (20 mg – Tab.)

This notice was published on August 25, 2022.

Acetaminophen (160 mg/5 ml – Liq.), and Acetaminophen (160 mg/5 ml – Liq.) replace:

• Acetaminophen
• Jamp-Acetaminophen
• PDP-Acetaminophen solution

This notice was published on September 13, 2022.

Heparin sodium replaces Heparin sodium injection, USP.

This notice was published on September 13, 2022.

Trifluoperazine hydrochloride replaces Trifluoperazine.

This notice was published on September 13, 2022.

Electrolyte replacement/dextrose replaces:

• Gastrolyte
• Jamp Rehydralyte

This notice was published on August 8, 2022

Hydroxyzine hydrochloride replaces:

• Hydroxyrine
• Novo-Hydroxyzin

This list was published on September 26, 2022.